Ebola Fever Therapy
Research from University of Alberta broadens understanding of ebola fever therapy
Published in Blood Weekly, August 9th, 2007
Current study results from the report, "Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens," have been published. "Ebola virus (EBOV) causes hemorrhagic fever in humans and nonhuman primates with up to 90% mortality rate. In this study, Ebola virus like particles (EVLPs) and the aglycosyl subfragment of glycoprotein (GP(1) subfragment D) were used to generate monoclonal antibodies (MAbs) against different epitopes of the viral antigens," investigators in Edmonton, Canada report.
"Such MAbs could be useful in diagnostics and potential therapeutics of viral infection and its hemorrhagic symptoms. Hybridoma cell...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-08-09)
More Articles from Blood Weekly
- Cancer
Cancer risk does not increase for recipients of blood transfusions from donors with undiagnosed cancer - Sickle Cell Anemia
Red Cell Substitute Shows Promise as Treatment for Sickle Cell Disease - Artificial Organs
German and French CardioWest Artificial Heart Patients Enjoy a Better Quality of Life Than Americans - Cerus Corporation
Grifols S.A. and Cerus Corporation Agree to Commercialize the INTERCEPT Blood System in Spain and Portugal - Clinical and Laboratory Standards Institute (CLSI)
CLSI Publishes Guideline on Platelet Function Testing by Aggregometry - Cord Blood
A Market Insight into the Progressing and Debatable Market of Stem Cell Research - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
